增强血管壁磁共振成像在血流导向装置治疗颅内动脉瘤随访中的应用
本研究纳入77例患者共84个血流导向装置治疗的动脉瘤,比较增强3D T1加权黑血快速自旋回波血管壁磁共振成像(eVW-MRI)与时间飞跃法磁共振血管造影(TOF MRA)在随访评估动脉瘤闭塞和载瘤动脉通畅性中的效能,以数字减影血管造影(DSA)为标准。结果显示eVW-MRI与DSA的一致性优于TOF MRA,尤其在有无弹簧圈伪影时检测动脉瘤残留及评估载瘤动脉通畅性方面。
要点
- eVW-MRI与DSA检测动脉瘤残留的加权ĸ=0.891,优于TOF MRA的0.553。
- eVW-MRI评估载瘤动脉通畅性与DSA的ĸ=0.950,优于TOF MRA的0.221。
- 辅助弹簧圈伪影下,eVW-MRI检测动脉瘤残留一致性仍优于TOF MRA(加权ĸ=0.891 vs 0.511)。
核心结论
- eVW-MRI在评估血流导向装置治疗后动脉瘤残留和载瘤动脉通畅性方面优于TOF MRA,是一种可靠的非侵入性、无电离辐射的影像方法;eVW-MRI序列上强化模式的意义仍需更多探索。
研究设计与样本
- 本研究纳入77例患者共84个血流导向装置治疗的动脉瘤,随访采用MRI(eVW-MRI和TOF MRA)及DSA,两名放射科医生在不了解DSA结果的情况下独立使用Kamran-Byrne量表评估动脉瘤闭塞和载瘤动脉通畅性,获取观察者间和模态间诊断一致性,并收集治疗前和随访的动脉瘤壁强化(AWE)模式。
关键影像表现/征象
- eVW-MRI与DSA检测动脉瘤残留的模态间一致性加权ĸ=0.891,TOF MRA与DSA为加权ĸ=0.553。
- eVW-MRI与DSA评估载瘤动脉通畅性的模态间一致性ĸ=0.950,TOF MRA与DSA为ĸ=0.221。
- 存在弹簧圈伪影时,eVW-MRI与DSA检测动脉瘤残留的一致性加权ĸ=0.891,TOF MRA为加权ĸ=0.511。
- 辅助弹簧圈伪影对TOF MRA评估载瘤动脉通畅性准确性的影响可能大于eVW-MRI(ĸ=0.077 vs 0.788)。
- 随访AWE模式与治疗前AWE模式及动脉瘤闭塞无显著关联。
诊断标准与关键数值
- 使用Kamran-Byrne量表评估动脉瘤闭塞和载瘤动脉通畅性。
- eVW-MRI与DSA检测动脉瘤残留的加权ĸ=0.891,TOF MRA与DSA为加权ĸ=0.553。
- eVW-MRI与DSA评估载瘤动脉通畅性的ĸ=0.950,TOF MRA与DSA为ĸ=0.221。
- 有弹簧圈伪影时,eVW-MRI与DSA检测动脉瘤残留的加权ĸ=0.891,TOF MRA为加权ĸ=0.511。
- 有辅助弹簧圈伪影时,TOF MRA评估载瘤动脉通畅性的ĸ=0.077,eVW-MRI为ĸ=0.788。
临床应用与阅片要点
- eVW-MRI可作为血流导向装置治疗后评估动脉瘤残留和载瘤动脉通畅性的无创、无电离辐射影像方法。
- eVW-MRI在检测动脉瘤残留和载瘤动脉狭窄方面优于TOF MRA,无论是否伴有辅助弹簧圈伪影,以DSA为标准。
- eVW-MRI有潜力作为DSA的替代方法用于血流导向装置治疗后的常规动脉瘤随访。
- eVW-MRI可用于描绘动脉瘤残留和载瘤动脉狭窄,以辅助制定抗血小板治疗策略。
- eVW-MRI序列上强化模式的意义仍需更多探索。
局限性
- eVW-MRI序列上强化模式的意义仍需更多探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to compare the efficacy of enhanced 3D T1-weighted black-blood fast-spin-echo vessel wall magnetic resonance imaging (eVW-MRI) and time-of-flight magnetic resonance angiography (TOF MRA) for follow-up evaluation of aneurysms treated with flow diversion (FD).
METHODS: Our study enrolled 77 patients harboring 84 aneurysms treated with FD. Follow-up was by MRI (eVW-MRI and TOF MRA) and digital subtraction angiography (DSA). Two radiologists, blinded to DSA examination results, independently evaluated the images of aneurysm occlusion and parent artery patency using the Kamran-Byrne Scale. Interobserver diagnostic agreement and intermodality diagnostic agreement were acquired. Pretreatment and follow-up aneurysm wall enhancement (AWE) patterns were collected.
RESULTS: Based on the Kamran-Byrne Scale, the intermodality agreement between eVW-MRI and DSA was better than TOF MRA versus DSA for aneurysm remnant detection (weighted ĸ = 0.891 v. 0.553) and parent artery patency (ĸ = 0.950 v. 0.221). Even with the coil artifact, the consistency of eVW-MRI with DSA for aneurysm remnant detection was better than that of TOF MRA (weighted ĸ = 0.891 v. 0.511). The artifact of adjunctive coils might be more likely to affect the accuracy in evaluating parent artery patency with TOF MRA than with eVW-MRI (ĸ = 0.077 v. 0.788). The follow-up AWE patterns were not significantly associated with pretreatment AWE patterns and aneurysm occlusion.
CONCLUSIONS: The eVW-MRI outperforms TOF MRA as a reliable noninvasive and nonionizing radioactive imaging method for evaluating aneurysm remnants and parent artery patency after FD. The significance of enhancement patterns on eVW-MRI sequences needs more exploration.
CLINICAL RELEVANCE STATEMENT: The application of enhanced vessel wall magnetic resonance imaging has proven to be a promising tool to depict aneurysm remnant and parent artery stenosis in order to tailor the antiplatelet therapy strategy in patients after flow diversion.
KEY POINTS: • Enhanced vessel wall magnetic resonance imaging has an emerging role in depicting aneurysm remnant and parent artery patency after flow diversion. • With or without the artifact from adjunctive coils, enhanced vessel wall magnetic resonance imaging was better than TOF MRA in detecting aneurysm residual and parent artery stenosis by using DSA imaging as the standard. • Enhanced vessel wall magnetic resonance imaging holds potential to be used as an alternative to DSA for routine aneurysm follow-up after flow diversion.
引用
- Quan T, Ren Y, Li J, et al. Enhanced vessel wall magnetic resonance imaging in the follow-up of intracranial aneurysms treated with flow diversion. Eur Radiol. 2023. PMID: 37580600. doi:10.1007/s00330-023-10094-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。